SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: horakloraine who wrote (2779)9/21/2012 1:15:44 PM
From: scaram(o)uche  Respond to of 3202
 
Yes, yes, and yes.

They might be able to compete, but they wouldn't be able to make much money off of it? I mean, if you want to, you could fill us in on their patent position. And with respect to that potential to compete, many of us have probably had our fill of resveratrol derivatives. I have. But good luck with it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News